Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Acta Neurochirurgica|August 9, 2023
Adverse events in spine surgery: a prospective analysis at a large tertiary center in GermanyPavlina Lenga, Philip Dao Trong, Vassilios Papakonstantinou, et al.
Neurosurgical Review|November 21, 2023
Reevaluating age restrictions of spinal metastasis surgery in elderly groups with over 2-year follow-upPavlina Lenga, Philip Dao Trong, Vassilios Papakonstantinou, et al.
Acta Neurochirurgica|April 21, 2022
The use of quantitative pupillometry in patients with pituitary tumors: a technical notePavlina Lenga, Martin Jakobs, Jessica Jesser, et al.
Acta Neurochirurgica|October 3, 2024
Tailored surgical approaches for spinal chordomas: A multidisciplinary perspectiveLukas Klein, Pavlina Lenga, Philip Dao Trong, et al.
Neurosurgical Review|February 15, 2025
Neurosurgical management of brain metastases in the elderly: a prospective study on adverse event prevalence and predictorsPavlina Lenga, Moritz Scherer, Helena Kleineidam, et al.
Brain & Spine|March 21, 2024
Prospective insights into spinal surgery outcomes and adverse events: A comparative study between patients 65-79 years vs. ≥80 years from a German tertiary centerPavlina Lenga, Philip Dao Trong, Vassilios Papakonstantinou, et al.
Acta Neurochirurgica|August 6, 2024
Advances in the multidisciplinary surgical approach to primary spinal sarcomas: insights from a retrospective case series on outcomes and survivalPavlina Lenga, Philip Dao Trong, Helena Kleineidam, et al.
International Journal of Molecular Sciences|September 28, 2018
Identification of a Prognostic Hypoxia-Associated Gene Set in IDH-Mutant GliomaPhilip Dao Trong, Saskia Rösch, Heimo Mairbäurl, et al.
Cells|June 7, 2020
Large-Scale Drug Screening in Patient-Derived IDHmut Glioma Stem Cells Identifies Several Efficient Drugs among FDA-Approved Antineoplastic AgentsPhilip Dao Trong, Gerhard Jungwirth, Tao Yu, et al.
International Journal of Cancer|July 10, 2026
Early Postoperative Adverse Events (≤ 30 Days) in Spinal Oncology: Defining the Incidence, Severity, and Predictors in a Mixed Prospective Cohort Including Intradural and Metastatic Spinal TumorsMeltem Ivren, Philip Dao Trong, Maximilian Klass, et al.
Pageof 4